# Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) System

> **NCT04794478** · NA · COMPLETED · sponsor: **DexCom, Inc.** · enrollment: 482 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DEVICE:** Dexcom Continuous Glucose Monitoring System

## Key facts

- **NCT ID:** NCT04794478
- **Lead sponsor:** DexCom, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-19
- **Primary completion:** 2021-08-09
- **Final completion:** 2021-10-31
- **Target enrollment:** 482 (ACTUAL)
- **Last updated:** 2022-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04794478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04794478, "Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) System". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04794478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*